Pharmacy benefit managers offer a wide range of clinical programs designed to improve health outcomes for members, while reducing overall healthcare costs. Plan sponsors may find it challenging to develop a process that effectively evaluates these programs. This paper explores industry best practices plan sponsors can use to consistently assess the value of both new and existing clinical programs.
Article
Given the greater flexibility and lower costs provided under ARPA’s provisions, plan sponsors should seize this moment to reevaluate and optimize their risk management strategies by considering the whole picture.